APA (7th ed.) Citation

Sae-sim, N., Samarnthai, N., & Numprasit, W. (2026). Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33 , 89". Current Oncology, 33(5), 248. https://doi.org/10.3390/curroncol33050248

Chicago Style (17th ed.) Citation

Sae-sim, Netchanok, Norasate Samarnthai, and Warapan Numprasit. "Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim Et Al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33 , 89"." Current Oncology 33, no. 5 (2026): 248. https://doi.org/10.3390/curroncol33050248.

MLA (9th ed.) Citation

Sae-sim, Netchanok, et al. "Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on "Sae-sim Et Al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33 , 89"." Current Oncology, vol. 33, no. 5, 2026, p. 248, https://doi.org/10.3390/curroncol33050248.